A new chapter for Uganda’s industrial and pharmaceutical landscape began in Busoga this week as H.E. President Yoweri Museveni commissioned the US$50 million (Shs182 billion) DEI BioPharma Starch Processing Factory in Busambu–Namasagali. This facility is the first phase of a…
In a landmark announcement, a new and highly effective HIV prevention drug, Lenacapavir, is set to be made available at a drastically reduced cost in over 100 low- and middle-income countries within the next two years. This breakthrough development offers…
Dei BioPharma has unveiled its next bold phase, announcing the commencement of Active Pharmaceutical Ingredient (API) manufacturing at its state-of-the-art facility in Matugga, on the outskirts of Kampala city. This massive undertaking, unveiled over the weekend by Dr. Mathias Magoola,…
The Uganda Cancer Institute (UCI) today launched the September Gold, Childhood Cancer Awareness Month, during which officials from the institute delivered a transformative message about cancer awareness among children in the country. Led by Dr. Joyce Balagadde Kambugu, the Head…
In a landmark achievement for African innovation, Dei BioPharma, a Ugandan pharmaceutical complex, has received a second major approval from the U.S. Food and Drug Administration (FDA), solidifying the country’s position as an emerging global hub for vital medicines. The…
The National Medical Stores (NMS) in Uganda is at the centre of a major public health alert following the recall of a defective and dangerous drug from all health facilities. A directive from NMS General Manager Moses Kamabare has ordered…
In a landmark achievement that resonates beyond its borders, Uganda has positioned itself at the forefront of global medical innovation, as the United States Patent and Trademark Office (USPTO) has formally accepted two groundbreaking vaccine patent applications by Dr. Mathias…
Stanbic Bank Uganda, under the leadership of Tunde Thorpe, the Executive Head of Business and Commercial Banking, over the weekend donated assorted equipment to Nyantabooma Health Centre III, in Kabarole District. The bank handed over essential medical equipment and 200…
A landmark moment in the global fight against HIV has been cemented with the U.S. Food and Drug Administration (FDA) approval of lenacapavir, a groundbreaking “super drug” for HIV prevention, after pivotal trials conducted right here in Uganda. This twice-a-year…
A Ugandan student, Emmanuel Kiyonga, has made a groundbreaking discovery in the field of pharmaceuticals, developing a drug that cures breast cancer. The drug, named Raloxifene Hydrochloride Solvate-Hydrate, is the first patent secured by the university. Kiyonga, a pharmacy graduate…
The visit of the National Drug Authority (NDA) to DEI Biopharma Limited’s facility today marks a significant milestone in not only Uganda’s but also Africa’s pharmaceutical industry. This event, according to Dr. Mathias Magoola, the founder and Managing Director of…
The equipment was delivered today to Mpugwe Health Centre III by a team from Stanbic Bank led by the Chief Executive Officer, Mumba Kenneth Kalifungwa, who hailed the medical personnel at the health facility for the great work they are…
The Ugandan government‘s decision to ban doctors and medical personnel employed by the state from owning and running private facilities is a move aimed at improving service provision in the health sector. This directive, set to take effect on July…
As hospitals across Uganda struggle with severe shortages of essential medicines, a report by the Auditor General has revealed a shocking case of mismanagement at the National Medical Stores (NMS), where expired drugs worth billions of shillings continue to pile…
The commissioning of Piston Medical, a state-of-the-art pharmaceutical factory located in Namanve Industrial Park, marks a significant milestone for Uganda’s healthcare and industrial sectors. With the capacity to produce 16 life-saving medical commodities, Piston Medical is poised to revolutionize the…